B-Cell::Lymphoma
Regulatory T cells but not NKT I cells are modulated by a single low dose cyclophosphamide in a B cell lymphoma tumor model
... two cell populations of the innate immune response with opposing effects on the tumors, in a rat B cell lymphoma ...L-TACB lymphoma and on day 14 animals were distributed in two ...
5
Clinical Characteristics of Primary Extranodal versus Nodal Diffuse Large B Cell Lymphoma: A Retrospective Cohort Study in a Cancer Center
... presence of a primary craniofacial involvement with- out regional nodal involvement and no other extrano- dal site involved. Cohort D corresponded to primary gastrointestinal site and included patients with either only ...
10
A prognostic score for survival in patients older than 65 years with Diffuse Large B Cell Lymphoma
... of B symptoms, > 2 extranodal sites, the presence of bulky disease, hemoglobin < 10 g/dL, levels of LDH higher than the upper nor- mal value, increased levels of beta-2 microglobulin, and albumin levels < ...
7
Differential Impact of Relative Dose Intensity Reductions in Diffuse Large B Cell Lymphoma Treated with R CHOP21 or R CHOP14
... However, treatment-related factors such as RDI are not always routinely considered. RDI represents the ratio of the amount of a drug actually administered to the amount planned for a fixed time period and is an important ...
11
"Anti-Neoplastic Properties of Black Bean Flavonoids in Diffuse Large B Cell Lymphoma"-Edición Única
... Some of the drugs that form part of the chemotherapy to treat the DLBCL come from natural sources as plants i.e. alkaloids of the vinca or from microorganisms like the estreptomyces peucetycus where Doxorrubicine is ...
146
Lovastatin enhances in vitro radiation induced apoptosis of rat B cell lymphoma cells
... The enzyme 3-hydroxy-3-methylglutaryl coen- zyme A (HMG-CoA) reductase catalyzes the synthe- sis of mevalonate (MV) from HMG-CoA, which con- stitutes the rate-limiting step in the biosynthesis of cholesterol (3). It has ...
8
Modulation of IL 10/IL 10R expression by mafosfamide, a derivative of 4 hydroxycyclophosphamide, in a rat B cell lymphoma
... including lymphoma. It was shown that the molecular signature of mantle cell lymphoma (MCL), a non- Hodgkin lymphoma, included overexpression of IL- 10R, and that IL-10 was able to sustain ...
6
Anti neoplastic properties of black bean flavonoids in diffuse large B cell lymphoma
... Step by step procedure was taken from [44]. These quality controls were performed using the DNA QC particles kit (Part. Number: 349523, Becton Dickinson Biosciences, San Jose, CA, USA) this kit contains four vials (A, ...
144
Cholestatic hepatitis C after chemotherapy containing rituximab in diffuse large B cell lymphoma
... served in our patient was a reflection of the failure of immune reconstitution, and it induced intracellu- lar oxidative stress and mitochondrial dysfunction, which in turn were responsible for the cholestatic damage. ...
6
Elucidating the role of SOX11 in mantle cell Iymphoma
... Mantle cell lymphoma (MCL) is one of the most aggressive lymphoid neoplasms whose pathogenesis is not fully ...mature B-cell lymphomas or normal lymphoid ...mature B-cell ...
287
Hairy cell leukemia, an uncommon B cell lymphoid neoplasia
... HCL must be distinguished from other indolent lymphoid neoplasias such as prolymphocytic leukemia, splenic marginal zone lymphoma, the variant of HCL (HCLv), and mantle cell lym- phoma. Peripheral blood ...
8
Linfoma anaplsico de clulas grandes asociado a implantes mamarios Importancia para el cirujano
... Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is an infrequent disease, although the number of cases has increased in the recent years. BIA-ALCL is revealed during medical screening as ...
6
Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis
... of cell division determined by staining tumor cells with carboxyfluorescein succinimidyl ...proliferating cell nuclear antigen and active caspase ...of cell cycle regulatory proteins was also ...the ...
13
Metaanlisis sobre los factores pronstico relacionados con la mortalidad en nios con leucemia linfoblstica aguda
... methods. The study selection was based on Medline. Using a peer-review process we identified the following group of publications: cohort studies of pediatric patients with ALL that were analyzed for prognostic factors ...
15
Paranasal sinuses lymphoma and past hepatitis B virus infection: possible association?
... hepatitis B core antibody (anti-HBc) with all the others hepatitis B virus (HBV) specific antigens and antibodies negative, probably as a result of a past HBV infection (Table ...
13
Bases moleculars de l’activitat antitumoral de la lenalidomida en el limfoma de cèl•lules del mantell
... inestabilitat genòmica incrementada. S’han trobat mutacions en ATM en el domini PI3K i aquestes són freqüentment acompanyades per la pèrdua de l’altre al·lel. L’elevada freqüència de mutacions d’aquest gen en el MCL ha ...
225
Extranodal NK/T-Cell Lymphoma without Nasal Cavity Involvement Associated with Epstein-Barr Virus:AMultimodality-Based Diagnosis of Two Cases
... To conclude, NK/T-cell lymphomas are tumors mainly caused in Asian and South American countries, but can also be produced in the Western population. These tumors mainly involve the nasal cavity although in some ...
5
Humanized anti CD123 antibody facilitates NK cell antibody dependent cell mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD 1
... Radioactivity was measured from the supernatants of each well using a gamma counter. The percentage of speci fi c lysis was calculated using the formula [(experimental release − spontaneous release)/(maximum release − ...
11
Diagnstico y tratamiento del linfoma cutneo de clulas T
... The most frequent types of cutaneous T-cell lymphomas (CTCL) in the practice of dermatology are mycosis fungoides and Sézary syndrome. It is important for the clinician to be acquainted with the initial management ...
10
Infectious Complications as a Predictor of Mortality in Patients with Non Hodgkin Lymphoma Receiving Rituximab Containing Chemotherapy
... Main outcome was response to chemotherapy, clas- sified as complete response (CR), partial response, progression, relapse, or death. Patients were consid- ered lost to follow-up ≥ 6 months after their past medical visit. ...
8